# FDA Inspection 1304588 - CoreRX Inc. - February 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/corerx-inc/956f34ef-816f-43f4-bdfd-ba4552b1e37e
Source feed: FDA_Inspections

> FDA Inspection 1304588 for CoreRX Inc. on February 26, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304588
- Company Name: CoreRX Inc.
- Inspection Date: 2026-02-26
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Office Name: Florida District Office

## Related Documents

- [FDA Inspection 1264769 - 2025-03-20](https://www.keypedia.com/records/fda_inspections/corerx-inc/2ad11a9c-e4df-4503-8667-a3b01206638f)
- [FDA Inspection 1151289 - 2021-08-13](https://www.keypedia.com/records/fda_inspections/corerx-inc/85fa8ce0-d79f-4073-a991-3e6bc3437b59)
- [FDA Inspection 1119912 - 2020-03-06](https://www.keypedia.com/records/fda_inspections/corerx-inc/bc103bf0-449a-4325-ade3-a111f8251fb5)
- [FDA Inspection 1027540 - 2017-09-27](https://www.keypedia.com/records/fda_inspections/corerx-inc/5dc2a719-2d30-4fea-aac4-3d3b22c4b12e)
- [FDA Inspection 932712 - 2015-06-19](https://www.keypedia.com/records/fda_inspections/corerx-inc/0223820a-068a-4561-a464-531862e6f326)

Company: https://www.keypedia.com/companies/corerx-inc/cca4f858-9ccd-498a-893b-22c5d29559aa

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9